Cortavance 0.584 mg (Hydrocortisone Aceponate SOLUTION) 0.584 MG

CORTAVANCE 0.584 MG is a topical solution containing hydrocortisone aceponate, designed for skin applications. It is commonly used for managing skin conditions that require anti-inflammatory treatment.

Strength

0.584 MG

Pack Size

76ML

Manufacturer / TM Owner

VIRBAC AH, INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CORTAVANCE 0.584 MG is primarily used for topical applications to address skin conditions that benefit from anti-inflammatory effects. It may be applied to areas affected by inflammation or irritation. Users often seek this solution for its potential to soothe and reduce redness. What is CORTAVANCE used for? It is generally used for conditions where a topical anti-inflammatory is recommended.

Side Effects

When applied topically, CORTAVANCE 0.584 MG may help reduce inflammation and soothe the skin. Users might notice a reduction in redness and irritation. The effects are typically localized to the area of application.

Precautions & Warnings

CORTAVANCE 0.584 MG should be used as directed. Avoid contact with eyes and mucous membranes. It is important to follow the instructions provided by a healthcare professional regarding the application and duration of use. Keep out of reach of children.

Avoid Interactions

CORTAVANCE 0.584 MG may interact with other topical treatments. It is advisable to consult a healthcare professional before combining it with other skincare products. Avoid using it with products that contain similar active ingredients to prevent potential skin irritation.

Frequently Asked Questions

CORTAVANCE 0.584 MG is used for topical applications to manage skin conditions that require anti-inflammatory treatment.

CORTAVANCE 0.584 MG should be applied topically to the affected area as directed by a healthcare professional.

Consult a healthcare professional before using CORTAVANCE 0.584 MG on sensitive skin to ensure it is suitable for your specific condition.

Common effects may include reduced inflammation and soothing of the skin, typically localized to the area of application.

The safety of long-term use should be discussed with a healthcare professional, as it may vary depending on individual circumstances.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.